This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Fat Profits: How Investors Can Capitalize on Obesity Battle

By Jeff Cox, Senior Writer

NEW YORK ( CNBC) -- More than one-third of Americas are considered obese, and investors looking to capitalize on the battle to reverse the trend could find themselves well-fed.

Getting financially fat off the "globesity" fight to help overweight Americans is the latest investing thesis from Bank of America Merrill Lynch, which believes global efforts to attack the problem will provide opportunities to make money.

The firm divides its recommendations across four sectors and more than 50 stocks that will benefit, particularly for those investors with longer time frames.

"Although it is difficult to accurately gauge the link between such exposure and share price performance, ... we still consider fighting obesity exposure an important and positive point to track, given that obesity is a sustainability megatrend with a 25-50 year lifespan," BofA equity analyst Sarbjit Nahal said in an analysis for clients.

More from CNBC
JPMorgan's Whale Tale: More To Come?
How Will the Drought Affect Consumer Food Prices?
Wall Street's Secret Weapon for Getting an Edge

Some 1.4 billion of the world's 7 billion residents are considered overweight, and 500 million are classified as obese, according to the World Health Organization.

In the U.S., the Centers for Disease Control and Prevention says 35.7% of the population is obese, with nine states having more than a 30% rate and no state under 20%.

Medical costs associated with obesity are currently around $150 billion a year, with those numbers only expected to climb.

Such statistics help make the case for the BoA fat-fighting play.

"This will require a 25-50 year 'systems perspective,' in our view, targeting multiple stakeholders and environments, going beyond health to include the food and beverage industry, schools, work environments, insurers tackling sedentary lifestyles and encouraging increasing physical activity," Nahal said.

The firm breaks its recommendations into four sectors: pharmaceuticals and health care; food; commercial weight loss, diet management and nutrition; and sports apparel and equipment.

Among the long list of stocks BofA recommends: The pharma plays include Allergan (AGN) and St. Jude Medical (STJ); while in food familiar names include ConAgra (CAG), Heinz (HNZ) and Panera (PNRA).

The four diet management and nutrition stocks on the list include Herbalife (HLF) and Weight Watchers (WTW), while the sports apparel and equipment space includes Under Armour (UA), Dick's (DKS) and Nike (NKE).

"We view Medicare's adoption of obesity counseling onto coverage as a significant step in recognizing obesity as a legitimate health concern," Nahal said.

Health care stocks have been solid performers in 2012, ranking fifth of the 10 sectors on the Standard & Poor's 500 with a 9.9% gain, though returns have slowed considerably in the second quarter.

--Written by Jeff Cox at CNBC
CNBC is a world leader in business news, providing real-time financial market coverage and business information.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.83 0.20%
FB $118.57 0.00%
GOOG $698.21 0.00%
TSLA $238.90 -1.20%
YHOO $36.53 0.00%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs